The Indian generic drug maker announced the approval of repaglinide tablets in the 1-mg and 2-mg strengths, which are used in combination with diet and exercise to improve blood-sugar control in patients with Type 2 diabetes.
The National Advertising Division recommended that German-American Technologies modify or discontinue certain advertising claims made for the company’s Nitraflex Hyperemia & Testosterone Enhancing dietary supplement.
One, a specialty brand of premium condoms in North America, on Tuesday announced the launch of One Move — a deluxe, long-lasting silicone lubricant — and One Oasis — a smooth, water-based lubricant that is paraben-free.
i-Health unveiled its Estroven Weight Management, a supplement specifically formulated to address the physical changes of menopause plus deliver on a core benefit of helping peri/menopausal women manage their weight as they go through this stage of life.
Sandoz has started a late-stage clinical trial of a biosimilar version of a drug used to treat autoimmune disorders, hoping the results will support its efforts to win regulatory approval in the United States and Europe.